This article summarized the latest R&D progress of urapidil, the Mechanism of Action for urapidil, and the drug target R&D trends for urapidil.

Attenuator in biotechnology refers to a nucleotide sequence in DNA that can lead to premature termination of transcription, a process found in bacteria and archaea.

This article summarized the latest R&D progress of viltolarsen, the Mechanism of Action for viltolarsen, and the drug target R&D trends for viltolarsen.

Yasheng Pharmaceutical presented updated clinical data for APG-1252 and Osimertinib to treat EGFR mutation lung cancer patients at the 2023 ESMO meeting on October 23, 2023.

This article summarized the latest R&D progress of tegafur, the Mechanism of Action for tegafur, and the drug target R&D trends for tegafur.

Merck Company published an article in the Journal of Medicinal Chemistry (JMC) on the 20th of this month, reporting on the discovery process of LRRK2 inhibitor MK1468.

This article summarized the latest R&D progress of teniposide, the Mechanism of Action for teniposide, and the drug target R&D trends for teniposide.

On October 24, 2023, BioNova Pharmaceuticals announced that the U.S. FDA has granted Fast Track Designation to its product BN104 for the treatment of relapsed/refractory acute leukemia.

This article summarized the latest R&D progress of tenofovir alafenamide fumarate, the Mechanism of Action for tenofovir alafenamide fumarate, and the drug target R&D trends for tenofovir alafenamide fumarate.

NF-κB is present in almost all animal cells and is a key transcription factor in various biological processes in the human body.

This article summarized the latest R&D progress of teprotumumab-trbw, the Mechanism of Action for teprotumumab-trbw, and the drug target R&D trends for teprotumumab-trbw.

The Drug Evaluation Center of the NMPA in China announced on Oct 24, 2023, on its official site, that Innovent Biologics' Category 1 new drug, GFH925 (IBI351), is slated for priority review.